Table 2.

CGM results and other clinical parameters before as well as 6 and 12 months after the switch from conventional CSII to SAP therapy

Parameter	Before the change to SAP	6 months after the change to SAP	12 months after the change to SAP
Duration of glucose range (min/h)
< 70 mg/dl
All day	6.6 ± 4.5	3.2 ± 4.1*	3.0 ± 2.8*
Daytime	7.1 ± 4.5	3.1 ± 4.0*	3.2 ± 3.0*
Nighttime	5.6 ± 7.2	3.1 ± 4.2	2.4 ± 2.9
70–180 mg/dl	35.7 ± 6.8	36.8 ± 7.8	38.1 ± 9.0
> 180 mg/dl	17.6 ± 8.5	20.0 ± 9.8	18.9 ± 10.2
AUC for glucose range [(min × mg/dl)/day]
< 70 mg/dl	1.4 ± 1.2	0.7 ± 1.1*	0.6 ± 0.7*
> 180 mg/dl	16.2 ± 9.2	18.3 ± 12.7	16.6 ± 14.4
Mean glucose level (mg/dl)	146.0 ± 24.8	158.3 ± 28.3	155.7 ± 28.5
SD of glucose level (mg/dl)	63.2 ± 12.1	59.6 ± 11.4	57.7 ± 11.9
MAGE (mg/dl)	117.9 ± 26.7	114.6 ± 20.4	106.4 ± 20.5
HbA1c (%)	7.8 ± 1.0	7.7 ± 0.9	7.4 ± 0.9*
TDD (U/day)	33.5 ± 12.7	34.3 ± 12.6	38.9 ± 15.2
TBD/TDD ratio (%)	29 ± 10	29 ± 7	28 ± 8

Data are mean ± SD

MAGE mean amplitude of glycemic excursions, TDD total daily dose of insulin, TBD total basal dose of insulin

*P < 0.05 versus before the switch to SAP therapy (paired Student’s t test)